caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1801936539

Matthew KatesMD

OtolaryngologyNew Rochelle, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,682
Unique beneficiaries
—
Total services
2,034
Distinct HCPCS
14
Medicare payment
$170K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 677 Otolaryngology providers in NY — top quintile (cohort median 888).
REFERRAL NETWORK

Where Matthew Kates's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 23 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
WHITE PLAINS HOSPITAL MEDICAL CENTER79234
HENNIGES, MARIAN6981
POSEN, BARBARA2731
Bradley Scharf
Ophthalmology · New Rochelle, NY
2129
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2030
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
2057
Eyad Hijazin
Internal Medicine · Larchmont, NY
1954
NEW YORK-PRESBYTERIAN/LAWRENCE HOSPITAL1826
RUBIN, MICHAEL1836
WING, MARIA1872
Bernard Gitler
Internal Medicine · New Rochelle, NY
1720
Rudabah Hasan
Endocrinology · New Rochelle, NY
1734
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
906
Beneficiaries
—
Total drug cost
$14K
Distinct drugs
16
Brand share
5.2%
Top prescribed drugs
Fluticasone Propionate333 claims
Ipratropium Bromide85 claims
Famotidine79 claims
Omeprazole65 claims
Fluocinolone Acetonide Oil57 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
89.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$566
Payment records
23
By payment type
Food and Beverage$566